Skip to main content

and
  1. Article

    Open Access

    Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer

    Hepatocellular carcinoma (HCC) is an aggressive malignancy without effective therapeutic approaches. Here, we evaluate the tumor-intrinsic mechanisms that attenuate the efficacy of immune checkpoint inhibitor ...

    Yunong **e, Haofeng Wu, Yimiao He, Linglin Liu, Ianto Bosheng Huang in Cell Death & Disease (2024)